semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Multiple Sclerosis Covid19 (Part A and B): ● Patient is outside of infectious period of COVID-19 defined as follows Patient with mild to moderate illness who are not severely immunocompromised At least 10 days have passed since symptoms first appeared and At least 24 hours have passed since last fever without the use of fever-reducing medications and Symptoms (e.g. cough, shortness of breath) have improved Patient with severe to critical illness or who are severely immunocompromised At least 10 days and up to 20 days have passed since symptoms first appeared At least 24 hours have passed since last fever without the use of fever-reducing medications and Symptoms (e.g. cough, shortness of breath) have improved Clinician-diagnosed MS treated or untreated with an approved DMT  (Part A and B) Concurrent immunosuppressive therapy, active systemic cancer, primary or acquired immunodeficiency (i.e., CVID, HIV infection) Active drug or alcohol abuse Other anti-CD20 therapy apart from OCR Uncontrolled diabetes mellitus End-organ failure (cardiac, pulmonary, renal, hepatic) Systemic lupus erythematosus (SLE) (Part B only) EDSS >6 Active infection (e.g., hepatitis)
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Multiple Sclerosis Memory Learning Relapsing-remitting or progressive multiple sclerosis people defined according to Mc Donald's revised in 2005 Age between ≥ 18 and ≤ 65 years old Cognitive complaint, with at least one deficient score at the initial neuropsychological examination (<5th percentile of the reference group), one of the scores of which concerns at least one test Have not had a definite relapse for at least 6 weeks Be at least 4 weeks away from a corticosteroid bolus Lack of neuroleptic treatment Patient with an Internet connection Signed informed consent  Severe cognitive deficit defined by obtaining a deficit score in more than six cognitive processes at the initial neuropsychological assessment Neuropsychological care Inability to receive oral and written information Inability to use the software (due in particular to motor and / or sensory difficulties) Neurological or psychiatric comorbidity, other than MS and anxiodepressive syndrome Patient with severe anxiodepressive syndrome (BDI> 27) Participation in an interventional study on cognitive functions Patient under legal protection, guardianship or curatorship Pregnant or breastfeeding women
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Muscle Weakness Major patient > 18 years old Admission for more than 24 hours in the ICU ward Stay must be at least 72 hours  Person with a neuromuscular pathology Person presenting an osteoarticular contraindication to mobilization Amputee Person under guardianship or curatorship Person not affiliated to a social security system Pregnant Women
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 14.0-999.0,  Adolescent Pregnancy All subjects must be able to read and write Spanish RCT will be limited to pregnant adolescents who are between the ages of 14-19 years and 12-34 weeks gestational age. Other caregivers (age 14 years or older) will be eligible if they are planning to be involved in infant care Only pregnant adolescents receiving outpatient prenatal care at INMP or San Bartolomé will be approached as potential participants Only pregnant adolescents who have been cleared by their attending doctor/nurse to engage in the approach/recruitment and interview procedure will be approached as potential participants All infants born to adolescents enrolled during pregnancy will be eligible to be enrolled after birth  Anyone unable to read and write Spanish Any pregnant adolescent known to have a severe fetal anomaly will not be approached Infants who are advised not to participate by their attending doctor or pediatrician Children or adolescents who are wards of the state will not be enrolled
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Complex Regional Pain Syndrome Type I for patients CRPS Type I (fulfilling Budapest for research) Suffering of CRPS in a distal limb (hand or foot) Age >18 years Pain lasting less than 6 months Good understanding of the French language for control Not suffering from chronic pain, including CRPS Age >18 years  for both group Known or suspected non-compliance, drug or alcohol abuse Inability to follow the procedures of the study, e.g. due to language problems, severe psychological disorders, dementia, etc For blood sample: diabetes and history of hepatitis B, C, D or HIV infection
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 18.0-55.0,  Relapsing Remitting Multiple Sclerosis Are 18 to 55 years of age at the time of signing the informed consent. 2. Are diagnosed with Relapsing Remitting Multiple Sclerosis (RRMS). 3. Are neurologically stable for ≥ 30 days prior to both Screening and Baseline. 4. One or more documented relapses within the 2 years before Screening 5. Have an EDSS score of 0 to 5.5 at Screening and Baseline (Day 1) 6. Women of childbearing potential must use effective method of contraception 7. Signed and dated informed consent  Diagnosed with progressive MS. 2. Disease duration > 10 years in participants with an EDSS ≤ 2.0 at Screening and Baseline (Day 1). 3. Immunologic disorder other than MS. 4. History or current diagnosis of other neurological disorders that may mimic MS. 5. History or current diagnosis of progressive multifocal leukoencephalopathy (PML). 6. History of myocardial infarction or cerebrovascular event within 6 months prior to Screening, 7. A history of attempted suicide within 6 months prior to Screening or a positive response to items 4 or 5 of the Columbia-Suicide Severity Rating Scale (C-SSRS) at Screening. 8. An episode of major depression within the last 6 months prior to Screening (clinically stable minor depression is not exclusionary). 9. History of cancer, except adequately treated basal cell or squamous cell carcinoma of the skin 10. Breastfeeding/lactating or pregnant women 11. Participants are excluded from participation in the study if taken prohibited medications/treatments. 12. Participation in any investigational drug study within 6 months or 5 half-lives of the investigational drug, whichever is longest, prior to Screening
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Chemotherapy Induced Peripheral Neuropathy (CIPN) Age ≥ 18 Cancer patients who are about to receive paclitaxel or nab-paclitaxel-based adjuvant, neoadjuvant, or palliative chemotherapy Eastern Cooperative Oncology Group (ECOG) performance status ≥ 2 Ability to provide informed consent as documented by signature Ability to read, write, and speak German  Patients with pre-existing neuropathy Prior chemotherapy with taxanes or other neurotoxic agents Diabetes mellitus Gastric cancer Inpatients Concomitant medications that are known to cause neuropathy Pregnancy or lactation Lack of safe contraception, defined as: female participants of childbearing potential, not using and not willing to continue using a medically reliable method of contraception for the entire study duration, such as oral, injectable, or implantable contraceptives, or intrauterine contraceptive devices, or who are not using any other method considered sufficiently reliable by the investigator in individual cases Significant uncontrolled cardiac disease (e.g. unstable angina) Patients with psychiatric, addictive or any disorder that prevents the patient from adhering to the protocol requirements, in the opinion of the investigator
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 25.0-55.0,  Neck Pain Age b/w 25-55 years Limited ROM Pain more than 3on NPRS Individuals having NDI score 15 = moderate,25-34 = severe  Radiculopathies Malignancy infection trauma
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 18.0-59.0,  Multiple Sclerosis Ability to provide informed consent Diagnosis of Clinically Isolated Syndrome (CIS) or Relapsing Remitting Multiple Sclerosis (RRMS) confirmed by McDonald 2010 EDSS < 6.5 at time of visit  Diabetes type I or II use of glucose regulating medications fasting blood glucose of > 126 mg/dl known cardiac or respiratory disease morbid obesity (BMI >40) steroid exposure within 4 weeks of enrollment pregnancy or current use of hormone replacement therapy
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Dysarthria Stroke Cantonese-speaking adults who had their first stroke and have suffered dysarthria post-stroke Both acute and chronic stroke participants will be recruited  Individuals with a personal or family history of epilepsy or seizures Individuals with a history of another neurological condition (which is not a result from the initial stroke) Individuals with a history of speech disorders, voice disorders, oro-maxillo-facial surgery involving the tongue and/or lip, severe cognitive impairment, severe aphasia In an unstable or serious medical condition Have a cardiac implant metallic foreign body implant and/or any medications that lower neural thresholds (e.g. antidepressants, neuroleptic agents, etc.)
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 18.0-55.0,  Multiple Sclerosis Male or female between 18 and 55 years old Understand and able to express themselves in French GROUP  Relapsing-remitting form (RRMS) With an EDSS < 4 (Expanded Disability Status Scale) No significant motor, cerebellar or somatosensory disorders of the upper limbs or visual disorders (EDSS specific parameter <2) No flare-up in the last 6 weeks No corticosteroids taken in the last 4 weeks GROUP  Lack of global cognitive deterioration (according to Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) standards)  Persons with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general affections, perceptive or dysarthric disorders preventing verbal communication or reading People with sensory disorders (visual and auditory) that interfere with the performance of neuropsychological tests Treatment with psychotropic drugs (except benzodiazepines and hypnotics) Refusal to participate after clear and fair information about the study Major persons under guardianship, under judicial protection, persons deprived of liberty Pregnant or breastfeeding women
Patient description: The patient is a 20 year old Caucasian female presents to the clinic with one-sided vision lost and facial weakness, dysarthria and numbness lasting for 1 day. She visited her PCP and underwent brain MRI which revealed a single plaque in the brainstem. After few months, she experienced lower extremities weakness led to balance problem. The second MRI revealed another lesion in the left cerebral hemisphere. The diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) is confirmed after the second MRI. Her past surgical history is significant for a C-section 2 years ago and she has a one child. She is divorced and is not currently in any sexual relationship. She smokes 10 cigarettes per day and drinks alcohol occasionally. She is working as an editor in a publisher company and she is happy that she can keep working from home most of the time. She is under the treatment of RRMS from 7 months ago.

Clinical trial eligibility criteria: eligible ages (years): 20.0-999.0,  Acute Stroke Dual Antiplatelet Therapy Statin Clinical diagnosis of ischemic stroke with National Institute of Health Stroke Scale (NIHSS) score of 1-8 An ischemic lesion on diffuse-weighted imaging located in the MCA perforator, or Heubner's artery territories or vertebro-basilar perforator territories at brain stem, with an axial diameter ≦ 20mm.- Branch atheromatous disease, defined by a visible lesion in three or more axial MRI cuts in the MCA perforator or Heubner's artery territories or infarcts that extended from the basal surface of the brainstem Ability to randomize within 24 hours of time last known free of new ischemic symptoms Head CT or MRI ruling out hemorrhage or other pathology, such as vascular malformation, tumor, or abscess, that could explain symptoms or contraindicate therapy Ability to tolerate high intensity medical therapy, including aspirin at a dose of 50-325 mg/day, clopidogrel with 300mg loading and 75mg after day 2 and high-intensity statin(either atorvastatin 40-80mg or rosuvastatin 20 mg/day) Pre-stroke mRS≦1  Age < 20 years In the judgment of the treating physician A candidate for thrombolysis, endarterectomy or endovascular intervention Receipt of any intravenous or intra-arterial thrombolysis within 1 week prior to index event Patients with more than 50% stenosis of the relevant arteries on magnetic resonance angiography (MRA), including intra or extra-cranial internal carotid artery, middle cerebral artery or basilar artery Patients with high risk of cardioembolic source, such as atrial fibrillation, acute myocardial infarction, severe heart failure or valvular heart disease Other determined stroke etiology, such as vasculitis, shock, antiphospholipid antibody syndrome and etc Gastrointestinal bleed or major surgery within 3 months prior to index event History of nontraumatic intracranial hemorrhage